HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marked reduction of mortality in salt-loaded Dahl salt-sensitive rats by the new, selective endothelin ETA receptor antagonist, J-105859.

AbstractOBJECTIVE:
To examine the chronic effects of a newly synthesized, potent and selective endothelin (ET) ETA receptor antagonist, J-1 05859, on mortality in salt-loaded Dahl salt-sensitive (DS) rats and to confirm the potential of this compound as an ETA antagonist
METHODS:
Vehicle and J-105859 were administered to salt-loaded DS rats for 12 weeks. Throughout the experimental period, blood pressure was measured continuously using a telemetry system and the survival rate was determined. The surviving animals were subsequently sacrificed and autopsy was performed. Binding and functional assays were also carried out to characterize J-1 05859.
RESULTS:
The Ki values of J-1 05859 for cloned human ETA and ETB were 0.025 and 48 nmol/l, respectively. J-105859 inhibited ET-1-induced contractions in rabbit iliac artery (pA2 = 10.08) and BQ-3020 (ETB agonist)-induced contractions in pulmonary artery (pA2 = 7.63). The pressor response to intravenous (i.v.) ET-1 (0.5 nmol/kg) was significantly inhibited by J-1 05859 at a dose of 0.03 mg/kg i.v. Chronic treatment with J-1 05859 [0.1 and 1 mg/kg per day orally (p.o.)] from the prehypertensive stage decreased the mortality of salt-loaded DS rats and markedly inhibited the development of brain lesions. The survival rates in the control and J-1 05859 (0.1 and 1 mg/kg per day) groups were 34, 80 and 100%, respectively. Development of hypertension was markedly inhibited at a dose of 1 mg/kg per day.
CONCLUSION:
J-105859 is a selective, potent, orally active ETA-selective antagonist ETA antagonists may reduce morbidity as well as mortality in salt-sensitive hypertension.
AuthorsM Okada, M Nishino, M Saito, T Ikeda, S Uehara, H Okada, K Niiyama, N Ohtake, T Hayama, M Nishikibe
JournalJournal of hypertension (J Hypertens) Vol. 18 Issue 12 Pg. 1815-23 (Dec 2000) ISSN: 0263-6352 [Print] England
PMID11132606 (Publication Type: Journal Article)
Chemical References
  • Alkanes
  • Endothelin Receptor Antagonists
  • Endothelins
  • J-105859
  • Peptide Fragments
  • Pyridines
  • Receptor, Endothelin A
  • BQ 3020
  • Sodium Chloride
Topics
  • Alkanes (pharmacology)
  • Animals
  • Blood Pressure (drug effects)
  • Endothelin Receptor Antagonists
  • Endothelins (pharmacology)
  • Humans
  • Hypertension (etiology, physiopathology, prevention & control)
  • Iliac Artery (drug effects)
  • In Vitro Techniques
  • Male
  • Peptide Fragments (pharmacology)
  • Pulmonary Artery (drug effects)
  • Pyridines (pharmacology)
  • Rabbits
  • Rats
  • Rats, Inbred Dahl
  • Rats, Sprague-Dawley
  • Receptor, Endothelin A
  • Sodium Chloride (administration & dosage)
  • Vasoconstriction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: